| Financial Ratios | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Return on Equity | -28.841 | -1.405 | -33.371 | -19.889 |
| Net Profit Margin | - | - | - | - |
| Debt to Asset Ratio | 31.601 | 28.688 | 26.821 | 17.387 |
| Cash Ratio | 215.432 | 122.55 | 338.221 | 456.745 |
| Quick Ratio | 765.799 | 813.648 | 1,428.073 | 1,244.033 |
| Current Ratio | 765.799 | 813.648 | 1,428.073 | 1,244.033 |
Avalo Therapeutics, Inc. (AVTX)
Avalo Therapeutics, Inc. (AVTX)